OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
5227$20.5056

Advanced Lithium Electrochemistry Cayman Co Ltd

Specialty ChemicalsVerified

The company's capital structure is characterized by a low debt-to-equity ratio of 0.12, indicating a conservative leverage position. Its liquidity position is assessed as low, with a current ratio of 1.85 and cash and equivalents of TWD 93,989,000. The price-to-book ratio of 2.62 suggests the market values the company at a premium to its book value, while the price-to-earnings ratio of 117.67 reflects a high valuation relative to earnings. Profitability metrics show a return on equity of 2.22% and a return on assets of 1.44%, both below the typical thresholds for high-performing specialty chemical firms. The company reported a net income of TWD 11,847,000 despite a significant operating loss of TWD -465,774,000, indicating a reliance on non-operating income or one-time gains to offset operational losses. The company's revenue is primarily concentrated in Asia, America, and Europe, with no disclosed segment breakdown. This geographic diversification may help mitigate regional economic risks, but the lack of segment-specific data limits the ability to assess the performance of individual markets. The company's revenue for the latest period was TWD 400,650,000, but the financial snapshot does not provide historical data to determine the growth trajectory. The outlook for the current fiscal year is not specified, and no numeric deltas are available to project future performance. Risk factors include a low liquidity risk and a low dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company has not disclosed any dilution sources, and the dilution potential is assessed as low. The absence of significant debt and the presence of cash reserves support the low liquidity risk assessment. Recent events include the latest financial filing, which shows a net income despite a large operating loss. No specific events such as regulatory changes, product launches, or strategic partnerships are disclosed in the provided data.

30-day price · 5227-0.15 (-0.6%)
Low$19.90High$23.95Close$23.20As of18 May, 00:00 UTC
Profile
CompanyAdvanced Lithium Electrochemistry Cayman Co Ltd
Ticker5227.TWO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Advanced Lithium Electrochemistry Cayman Co Ltd develops and sells cathode materials for lithium phosphate batteries, including lithium iron phosphate (LFP), lithium vanadium fluorophosphate (LVPF), lithium manganese iron phosphate (LMFP), and other phosphate and ternary oxide materials, primarily serving markets in Asia, America, and Europe.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

The company's capital structure is characterized by a low debt-to-equity ratio of 0.12, indicating a conservative leverage position. Its liquidity position is assessed as low, with a current ratio of 1.85 and cash and equivalents of TWD 93,989,000. The price-to-book ratio of 2.62 suggests the market values the company at a premium to its book value, while the price-to-earnings ratio of 117.67 reflects a high valuation relative to earnings. Profitability metrics show a return on equity of 2.22% and a return on assets of 1.44%, both below the typical thresholds for high-performing specialty chemical firms. The company reported a net income of TWD 11,847,000 despite a significant operating loss of TWD -465,774,000, indicating a reliance on non-operating income or one-time gains to offset operational losses. The company's revenue is primarily concentrated in Asia, America, and Europe, with no disclosed segment breakdown. This geographic diversification may help mitigate regional economic risks, but the lack of segment-specific data limits the ability to assess the performance of individual markets. The company's revenue for the latest period was TWD 400,650,000, but the financial snapshot does not provide historical data to determine the growth trajectory. The outlook for the current fiscal year is not specified, and no numeric deltas are available to project future performance. Risk factors include a low liquidity risk and a low dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company has not disclosed any dilution sources, and the dilution potential is assessed as low. The absence of significant debt and the presence of cash reserves support the low liquidity risk assessment. Recent events include the latest financial filing, which shows a net income despite a large operating loss. No specific events such as regulatory changes, product launches, or strategic partnerships are disclosed in the provided data.
Key takeaways
  • The company maintains a conservative capital structure with a low debt-to-equity ratio of 0.12.
  • Despite a net income, the company reported a significant operating loss, indicating operational inefficiencies.
  • The company's geographic exposure is diversified across Asia, America, and Europe, but segment-specific data is not available.
  • The company's liquidity position is assessed as low, but the current ratio of 1.85 and cash reserves suggest short-term solvency.
  • The company's valuation is high, with a price-to-earnings ratio of 117.67 and a price-to-book ratio of 2.62.
  • The company's profitability metrics are below industry norms, with a return on equity of 2.22% and a return on assets of 1.44%.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$400.6M
Gross profit-$28.3M
Operating income-$465.8M
Net income$11.8M
R&D
SG&A
D&A
SBC
Operating cash flow-$322.6M
CapEx-$79.2M
Free cash flow$2.2M
Total assets$824.4M
Total liabilities$291.7M
Total equity$532.6M
Cash & equivalents$94.0M
Long-term debt$63.7M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$400.6M-$465.8M$11.8M$2.2M
FY-1$591.3M-$233.9M-$235.3M-$252.9M
FY-2
FY-3$707.5M-$379.7M-$398.1M-$401.0M
FY-4$312.9M-$272.4M-$558.7M-$506.4M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$824.4M$532.6M$94.0M
FY-1$1.05B$520.9M$0.00
FY-2
FY-3$1.30B$714.0M
FY-4$1.10B$496.7M$217.1M
PeriodOCFCapExFCFSBC
FY0-$322.6M-$79.2M$2.2M
FY-1-$248.9M-$78.7M-$252.9M
FY-2
FY-3-$336.8M-$84.2M-$401.0M
FY-4-$237.0M-$26.4M-$506.4M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$64.1M-$204.3M-$191.8M-$208.7M
FQ-1$49.6M-$99.5M$340.1M$350.7M
FQ-2$92.7M-$112.9M-$100.9M-$110.5M
FQ-3$194.2M-$49.1M-$35.6M-$29.3M
FQ-4$175.5M-$26.3M-$31.6M-$42.5M
FQ-5$133.2M-$75.5M-$66.2M-$68.1M
FQ-6$168.5M-$51.0M-$54.5M-$62.2M
FQ-7$114.0M-$81.0M-$82.9M-$80.1M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$824.4M$532.6M$94.0M
FQ-1$1.54B$724.0M$45.0M
FQ-2$1.03B$383.5M$0.00
FQ-3$1.06B$485.6M$0.00
FQ-4$1.05B$520.9M$0.00
FQ-5$1.09B$552.8M$20.0M
FQ-6$1.15B$619.3M$61.5M
FQ-7$1.19B$673.4M$45.5M
PeriodOCFCapExFCFSBC
FQ0-$322.6M-$79.2M-$208.7M
FQ-1-$216.4M-$45.8M$350.7M
FQ-2-$79.0M-$38.3M-$110.5M
FQ-3-$4.2M-$10.1M-$29.3M
FQ-4-$248.9M-$78.7M-$42.5M
FQ-5-$227.3M-$52.1M-$68.1M
FQ-6-$239.3M-$34.8M-$62.2M
FQ-7-$196.0M-$12.0M-$80.1M
Valuation
Market price$20.50
Market cap$1.39B
Enterprise value$1.36B
P/E117.7
Reported non-GAAP P/E
EV/Revenue3.4
EV/Op income
EV/OCF
P/B2.6
P/Tangible book2.6
Tangible book$532.6M
Net cash$30.3M
Current ratio1.9
Debt/Equity0.1
ROA1.4%
ROE2.2%
Cash conversion-27.2%
CapEx/Revenue-19.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric5227Activity
Op margin-116.3%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin3.0%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin-7.1%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-19.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity12.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 01:38 UTC#ea8d809f
Market quoteclose TWD 20.50 · shares 0.07B diluted
no public URL
2026-05-12 01:38 UTC#c9eb9dfa
Source: analysis-pipeline (hybrid)Generated: 2026-05-12 01:41 UTCJob: f92610bf